Order Article Reprints

Morroni G, Bressan R, Fioriti S, D’Achille G, Mingoia M, Cirioni O, Di Bella S, Piazza A, Comandatore F, Mauri C, et al. Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341. Antibiotics. 2022; 11(4):464. https://doi.org/10.3390/antibiotics11040464

Morroni, Gianluca, Raffaela Bressan, Simona Fioriti, Gloria D’Achille, Marina Mingoia, Oscar Cirioni, Stefano Di Bella, Aurora Piazza, Francesco Comandatore, Carola Mauri, and et al. 2022. "Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341" Antibiotics 11, no. 4: 464. https://doi.org/10.3390/antibiotics11040464

Morroni, G., Bressan, R., Fioriti, S., D’Achille, G., Mingoia, M., Cirioni, O., Di Bella, S., Piazza, A., Comandatore, F., Mauri, C., Migliavacca, R., Luzzaro, F., Principe, L., & Lagatolla, C. (2022). Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341. Antibiotics, 11(4), 464. https://doi.org/10.3390/antibiotics11040464